Profound Medical Corp.: regulation FD disclosure on TULSA-PRO abstracts

What happened

• The filing says that on Oct 14, 2026 Profound Medical Corp. issued a press release announcing abstracts related to the company's TULSA-PRO system presented at the 15th Interventional MRI Symposium.
• The press release is furnished as Exhibit 99.1 to the Current Report on Form 8-K. The report is signed by Arun Menawat, Chief Executive Officer and Chairman.

Key details

• Item reported: Item 7.01, Regulation FD Disclosure.
• Press release date and filing date: Oct 14, 2026.
• Event: abstracts related to the TULSA-PRO system presented at the 15th Interventional MRI Symposium.
• Exhibit furnished: Exhibit 99.1 (press release).

Why it may matter

• Item 7.01 covers Regulation FD Disclosure, specifically the company furnishing a press release as an exhibit to the Form 8-K about clinical abstracts.
• A filing does not show why the insider traded or why the company acted.